Clinical Trial Update: The Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases)

View source ↗

Summary

This document describes a recruiting clinical trial evaluating PET/CT imaging with 18F-FDG and 68Ga-FAPI tracers to diagnose and evaluate treatment efficacy in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 18F-FDG (fluorodeoxyglucose F-18)
• 68Ga-FAPI (gallium-68 labeled fibroblast activation protein inhibitor)

Snippet

Sponsor: Ruijin Hospital | Conditions: Advanced Colorectal Cancer | Status: RECRUITING